Though it's still struggling with data integration, Detroit's Henry Ford Health System is standardizing workflows and beginning to measure outcomes.
GenoVic will provide workflow management, variant interpretation, and a data repository that supports various analytics tools for clinicians across the state of Victoria.
Two years in, the MUSC Program for Human Microbiome Research is finding its footing, but it has high ambitions for creating safer care environments.
Hospital will partner with several other institutions in this effort to support data-driven research into pediatric cancers and structural birth defects.
The free genetic testing program has amassed genetic data and samples from more than 5,000 patients that researchers can now apply to access.
The company will develop a data warehouse that integrates whole-genome sequence, medical, and wearables data from patients and controls.
The company said it will use the funds to complete and launch Mastermind, its flagship product for analyzing and interpreting variant data.
BIG offers free use of the warehouse to internal researchers and is reaching out to local companies in the Buffalo area working in genomics and other areas.
Omicia will use the proceeds to accelerate product development, expand sales and marketing, and extend variations of its flagship Opal Clinical platform for NGS data analysis.
Dell plans to begin allowing clinical customers to store genomic datasets alongside patients' medical imaging data this spring.
The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.
A small study finds differences between three genomic prostate cancer tests, Medscape reports.
A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.
In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.